N
Novalent Biotech
Novalent produces products that inhibit the growth of microorganisms
About Novalent Biotech
Novalent is a US-based biotechnology engineering firm specializing in antimicrobial solutions that provide extended protection against bacteria and fungi. The company's patented technology forms a non-toxic monomolecular layer that inhibits microbial growth for up to 90 days on surfaces and up to 24 hours on human skin. Novalent's products are utilized by major corporations such as PepsiCo, Pilgrims, and HanesBrands, reflecting its strong presence in sectors like healthcare, animal housing, and food processing. The firm operates on a business-to-business model, generating revenue through partnerships and sales to large enterprises. Headquartered in Greensboro, North Carolina, Novalent has a global reach with sales offices in five locations worldwide. The company's strategic partnership with NISSCO further enhances its market penetration. Novalent's innovative approach addresses the limitations of traditional sanitizers, which lose efficacy once dry, by offering a solution that continuously protects treated surfaces.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2021 | $11M | $44M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Novalent Biotech is 70 monthly website visits, down 56.3% over the last three months. Novalent Biotech's team declined 38.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Novalent Biotech in the Greensboro ecosystem
The Novalent Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Novalent Biotech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Novalent Biotech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





